Principal Financial Group
RUBY

Principal Financial Group’s Rubius Therapeutics, Inc RUBY Stock Holding History

Principal Financial Group’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,417
Closed -$5K – 2583
2022
Q3 		$5K Buy
10,417
+310
+3% +$232 ﹤0.01% 2491
2022
Q2 		$9K Sell
10,107
-70
-0.7% -$117 ﹤0.01% 2507
2022
Q1 		$56K Sell
10,177
-572
-5% -$3.63K ﹤0.01% 2481
2021
Q4 		$104K Sell
10,749
-5,381
-33% -$74.6K ﹤0.01% 2440
2021
Q3 		$288K Sell
16,130
-2,611
-14% -$56.8K ﹤0.01% 2319
2021
Q2 		$457K Buy
+18,741
New +$469K ﹤0.01% 2238
2020
Q4 		– Sell
-16,236
Closed -$81K – 2474
2020
Q3 		$81K Sell
16,236
-804
-5% -$4.26K ﹤0.01% 2279
2020
Q2 		$102K Buy
17,040
+5,413
+47% +$32K ﹤0.01% 2247
2020
Q1 		$52K Hold
11,627
– – ﹤0.01% 2150
2019
Q4 		$110K Sell
11,627
-137
-1% -$1.32K ﹤0.01% 2181
2019
Q3 		$92K Sell
11,764
-380
-3% -$4.43K ﹤0.01% 2186
2019
Q2 		$191K Buy
+12,144
New +$196K ﹤0.01% 2152

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group's RUBY Position: Q4 2022 in Review

Principal Financial Group sold out of Rubius Therapeutics, Inc (RUBY) in Q4 2022, closing a stake of 10,417 shares — an estimated $5K sold.

Principal Financial Group first reported a position in RUBY in Q2 2019 and held it in 12 quarters. The position peaked at $457K in Q2 2021. 42 funds tracked by Wall St. Rank hold RUBY as of Q4 2022.

  • Principal Financial Group reported no remaining Rubius Therapeutics, Inc position as of Q4 2022 after selling out during the quarter.
  • Principal Financial Group sold 10,417 Rubius Therapeutics, Inc shares in Q4 2022, an estimated $5K.
  • Principal Financial Group first reported a position in Rubius Therapeutics, Inc in Q2 2019 and held it in 12 quarters.
  • Principal Financial Group's Rubius Therapeutics, Inc position peaked at $457K in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q4 2022.

Based on Principal Financial Group's 13F filing for Q4 2022, filed 9 Feb 2023.